Medibank Private Ltd upgrades profit forecast: Should you buy?

At today's prices, is Medibank Private Ltd (ASX:MPL) a likely outperformer?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Initial Public Offering (IPO) of Medibank Private Ltd (ASX: MPL) at the end of 2014 was a success; shares have remained above their offer price in the 15 months since. For a launch so heavily bought into by household investors, this was a vital consideration.

Yet the performance of the business improved as well. Revenues rose, profits were up, profit margins improved, and the company paid a 5.3 cent dividend equivalent to a yield of 4% for those that bought the stock in the IPO.

Earlier this morning, the company also announced a profit upgrade for the first half of 2016 as a result of improved claim outcomes (including reducing improper claims), improved hospital contracting and a slowdown in hospital utilisation growth.

Lower-than-expected new sales impacted first-half revenue growth however. Although the below results are not audited, shareholders should expect:

  • Premium revenue growth of between 4.5% and 5% (previous guidance: 'above 5.5%')
  • Management expense ratio of 8.5% (previous guidance: '8.3%')
  • Operating profit of above $470m (previously 'above $370m')
  • Second half operating profit is expected to be lower than first half

It looks as though Medibank's performance could be improving, after a number of concerning signs in the full year 2015 report.

In 2015 management reported growth in the number of members was below the market average and that average revenue per user grew by only 4.6%, despite 6.5% (1 April 2014) and 6.59% (1 April 2015) legislated increases in premium rates.

Management stated that slower revenue growth per user was due to changing product mix, as well as customer reductions in cover. Medibank also reported that its low-cost ahm brand continues to grow rapidly. Both of these facts indicate to me that the company is having to compete on price, which is not a method for growing shareholder wealth – unless volumes are growing rapidly, which they aren't.

Today's update however indicates that Medibank is making some progress, although it will continue to struggle to gain revenue as a result of a relatively small market, and stiff competition from players like Bupa and NIB Holdings Limited (ASX: NHF).

With regards to profitability, Medibank statistics show that a small portion of customers account for a disproportionate percentage of claim payments, so there could be further room to grow profits by reducing claims and promoting positive health behaviours.

While legislated premium increases and a focus on claims should deliver growth over time – assuming Medibank maintains its market position – it is unlikely to deliver stellar results unless Medibank can start taking market share from competitors.

Swelling profits at Medibank (or growing market share, for that matter) could simply intensify price competition, and Medibank continues to compete on price with its competitors.

For these reasons, and despite the positive update, I do not believe Medibank Private is a 'buy' today.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »